| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/08/2001 | US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents |
| 05/08/2001 | US6228889 Methods for treatment of conditions associated with lactosylceramide |
| 05/08/2001 | US6228882 Pyronin antibacterials, process and novel intermediates thereto |
| 05/08/2001 | US6228872 Neurotrophic diamide and carbamate agents |
| 05/08/2001 | US6228860 Substituted 1,3-oxathiolanes with antiviral properties |
| 05/08/2001 | US6228859 Antiasthmatic, antiinflammatory, antiallergen and antidepressant agents |
| 05/08/2001 | US6228846 Polynucleotide vaccine formula against canine pathologies |
| 05/08/2001 | US6228838 Bactericide or antibiotic screening; genetic engineering |
| 05/08/2001 | US6228835 Decorin binding protein compositions |
| 05/08/2001 | US6228834 Treating gramnegative bacterial infections; neutralizing lipopolysaccharides |
| 05/08/2001 | US6228642 Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression |
| 05/08/2001 | US6228622 Fungicide for medical and agricultural use |
| 05/08/2001 | US6228619 Glucosaminidase |
| 05/08/2001 | US6228617 Nucleotide sequence coding a trigger chaperone protein; for use in screening bactericides |
| 05/08/2001 | US6228614 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 05/08/2001 | US6228608 Recombinant FIV glycoprotein 160 and P24 gag protein |
| 05/08/2001 | US6228584 Nucleotide sequences for use in the detection of streptococcus |
| 05/08/2001 | US6228576 Detecting enzymes inhibitor of a preferential polymerase; incubate sample and inhibitor, detect polymerase activity |
| 05/08/2001 | US6228372 Polypeptides with amino acid sequences and peptides |
| 05/08/2001 | US6228369 Dna sequence codes, tat protein of hiv virus, rev protein and codes, glutamine residues |
| 05/08/2001 | US6228368 Antigens for human papilloma virus capsomere and fusion proteins adjacent to amino acid residues |
| 05/08/2001 | US6228364 Isolation of polypeptides with sequences |
| 05/08/2001 | US6227304 Upper hitch link |
| 05/08/2001 | US6227195 Coarse spray delivery of functional biologic material |
| 05/08/2001 | CA2096010C Recombinant feline coronavirus s proteins |
| 05/08/2001 | CA2087003C Hrsv vaccine |
| 05/08/2001 | CA2066661C Viral vaccine conjugates |
| 05/08/2001 | CA2011896C Ringworm vaccine |
| 05/03/2001 | WO2001031051A2 Antisense modulation of protein kinase c-theta expression |
| 05/03/2001 | WO2001031046A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | WO2001031045A1 Mammalian-type glycosylation in plants |
| 05/03/2001 | WO2001031016A2 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | WO2001031005A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | WO2001031003A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | WO2001030852A1 Production of immunoglobulins which binds heterologous fcr with modified affinity |
| 05/03/2001 | WO2001030846A1 Beta-defensins |
| 05/03/2001 | WO2001030815A1 Redox reversible hcv proteins with native-like conformation |
| 05/03/2001 | WO2001030814A1 Deglycosylated env/cd4 complex and the use thereof for vaccination against hiv |
| 05/03/2001 | WO2001030812A2 Activation of hcv-specific t cells |
| 05/03/2001 | WO2001030806A1 Polynucleotides and polypeptides involved in biofilm biology and their uses |
| 05/03/2001 | WO2001030795A1 Hygromycin derivatives |
| 05/03/2001 | WO2001030793A1 Hygromycin a prodrugs |
| 05/03/2001 | WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| 05/03/2001 | WO2001030775A1 Novel indole compounds |
| 05/03/2001 | WO2001030774A1 Substituted indoles for modulating nfkb activity |
| 05/03/2001 | WO2001030766A1 Phthalazinone derivatives as pde 4 inhibitors |
| 05/03/2001 | WO2001030757A1 Drug discharge pump inhibitors |
| 05/03/2001 | WO2001030754A2 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | WO2001030752A2 Indole compounds for treating bacterial infections |
| 05/03/2001 | WO2001030734A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 05/03/2001 | WO2001030395A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 05/03/2001 | WO2001030392A2 Delivery of proteins across polar epithelial cell layers |
| 05/03/2001 | WO2001030390A2 Method |
| 05/03/2001 | WO2001030384A1 Vaccine compositions |
| 05/03/2001 | WO2001030383A2 Medicament in order to induce tolerance |
| 05/03/2001 | WO2001030375A2 Use of gdnf for treating corneal defects |
| 05/03/2001 | WO2001030333A2 Tissue factor antagonists and methods of use thereof |
| 05/03/2001 | WO2001030329A2 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction |
| 05/03/2001 | WO2001030327A2 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of ischaemic conditions |
| 05/03/2001 | WO2001030317A1 Treatment and prevention of herpes simplex infections |
| 05/03/2001 | WO2001030300A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | WO2001030149A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 05/03/2001 | WO2001030148A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 05/03/2001 | WO2000078946A3 Treatment of viral influenza with antisense oligonucleotides |
| 05/03/2001 | WO2000076537A3 Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases |
| 05/03/2001 | WO2000074712A3 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 05/03/2001 | WO2000068263A3 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 05/03/2001 | WO2000065028A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 05/03/2001 | DE19951970A1 Arzneimittel für die Toleranzinduktion Medicines for tolerance induction |
| 05/03/2001 | DE19951701A1 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten Use of 2-imidazolyl-substituted carbinols of manufacturing a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions |
| 05/03/2001 | DE19951360A1 Substituierte Indole Substituted indoles |
| 05/03/2001 | DE19950632A1 New peroxochloric acid, used, optionally in salt form, as drug e.g. for promoting tissue regeneration, wound healing or immune response or as oxidizing agent, disinfectant, preservative or bleach |
| 05/03/2001 | CA2721011A1 Modified gp100 and uses thereof |
| 05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | CA2389256A1 Beta-defensins |
| 05/03/2001 | CA2389217A1 Mammalian-type glycosylation in plants |
| 05/03/2001 | CA2389191A1 Hygromycin derivatives |
| 05/03/2001 | CA2389019A1 Hygromycin a prodrugs |
| 05/03/2001 | CA2388995A1 Method |
| 05/03/2001 | CA2388974A1 Medicament in order to induce tolerance |
| 05/03/2001 | CA2388956A1 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of ischaemic conditions |
| 05/03/2001 | CA2388934A1 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | CA2388724A1 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388338A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | CA2388121A1 Phthalazinone derivatives as pde 4 inhibitors |
| 05/03/2001 | CA2388077A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 05/03/2001 | CA2387921A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | CA2387857A1 Tissue factor antagonists and methods of use thereof |
| 05/03/2001 | CA2387666A1 Redox reversible hcv proteins with native-like conformation |
| 05/03/2001 | CA2387378A1 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | CA2385929A1 Use of gdnf for treating corneal defects |
| 05/02/2001 | EP1096021A2 Melanins with improved ability to inhibit HIV replication |
| 05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
| 05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095947A1 Novel antibacterial compounds |
| 05/02/2001 | EP1095662A1 New vaccine composition and use of surfactants as immuno-adjuvant |
| 05/02/2001 | EP1095661A1 Prevention and treatment of biomaterial-associated infections |
| 05/02/2001 | EP1095657A2 Compositions for the regulation of cytokine activity |